CD163 Inhibitors

CD163 is a scavenger receptor exclusively expressed on the surface of monocytes and macrophages. Its primary role is the binding and internalization of haptoglobin-hemoglobin complexes, which are produced during the breakdown of red blood cells. By clearing these complexes, CD163 plays a pivotal role in iron recycling and inflammation resolution, ensuring that free hemoglobin, a potent oxidant, is efficiently removed from the bloodstream. Additionally, CD163 is involved in several other physiological processes, including the modulation of inflammatory responses, tissue repair, and anti-inflammatory signaling. Given its distinctive expression pattern and its multifaceted role in macrophage biology, CD163 is often used as a marker to distinguish between various macrophage populations, especially in the context of disease and tissue injury. Inhibitors targeting CD163 are molecules designed to specifically interfere with the function or expression of this receptor. The underlying rationale for developing these inhibitors is to modulate the activities of macrophages in certain pathological contexts. For instance, overactivation or prolonged activity of CD163-positive macrophages can contribute to excessive anti-inflammatory responses, suppressing necessary immune reactions or fostering an environment conducive to tumor growth. By inhibiting CD163, one might be able to alter the balance of pro-inflammatory and anti-inflammatory macrophages, influencing the overall immune response.